Pharmaceutical Drug Pricing: A Look at Reputation and the Media Landscape for Medicine
There is a chasm that exists between the negative perception of the pharmaceutical industry among the American public and the positive impact this industry has brought to bear through scientific advancements and new treatments. This gap is distinctly driven by the cost of medicines. In this report, we assess some of the distinct reputational challenges that biopharmaceutical companies face, the groups posing those challenges and what those arguments look like in the news media.
To view open FleishmanHillard positions, visit the Careers page.